Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Unaudited Financial Results for ....
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has informed BSE that its Board of Directors will meet on Tuesday, August 12, 2025, to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine regulatory filing under SEBI's Listing Regulations to give advance notice of the results announcement. The company has also confirmed that the trading window for insiders remains closed from July 1, 2025 to August 15, 2025, meaning directors and key employees cannot trade in the stock during this period. No financial numbers or business details have been disclosed in this intimation — only the meeting schedule and procedural information.
This is a standard advance notice with no direct impact on the stock. Investors should watch for the actual Q1 results on or after August 12, 2025, which will give the first read on Abbott India's performance for FY26. The closed trading window signals that insider activity is restricted until results are published.